open access

Vol 68, No 2 (2010)
Letters to the Editor
Published online: 2010-04-22
Submitted: 2012-12-28
Get Citation

Transcatheter closure of left atrial appendage with the Amplatzer® Cardiac Plug in patients with atrial fibrillation and high risk of thromboembolic events - early experience

Marcin Demkow, Adam Witkowski, Łukasz Cedzyński, Marek Konka, Jai-Wun Park, Anna Wojno, Tomasz Hryniewiecki, Witold Rużyłło
Kardiol Pol 2010;68(2):250-254.

open access

Vol 68, No 2 (2010)
Letters to the Editor
Published online: 2010-04-22
Submitted: 2012-12-28

Abstract

Background: Atrial fibrillation is the most common arrythmia in patients beyond 65 years of age. Several of those patients have contraindications to coumadin treatment. Ninety percent of atrial thrombi related to atrial fibrillation are found in the left atrial appendage.
Aim: We present our early experience with the left atrial appendage transcatheter closure using the Amplatzer® Cardiac Plug.
Methods: Transcatheter closure was performed in general anaesthesia and under transoesophageal echocardiography control in three patients aged 69, 73 and 61 years (two female). All had atrial fibrillation with high risk of thromboembolic events (CHADS2 score ≥ 2 points). In all of them coumadin treatment was contraindicated.
Results: The procedure time was 112, 109 and 60 min (fluoroscopy time: 25, 29 and 12,5 min). The Amplatzer® Cardiac Plugs of 24, 26 and 22 mm were implanted successfully and without complications. The day after, transthoracic echocardiogram revealed proper position of the implant and complete occlusion of the appendage in all patients. The patients were discharged on antiplatelet treatment.
Conclusion: Transcatheter left atrial appendage closure with the Amplatzer® Cardiac Plug may be a promissing therapeutic option for patients with atrial fibrillation-related high risk of thromboembolic events and with contraindications to anti-vitamin K treatment.

Abstract

Background: Atrial fibrillation is the most common arrythmia in patients beyond 65 years of age. Several of those patients have contraindications to coumadin treatment. Ninety percent of atrial thrombi related to atrial fibrillation are found in the left atrial appendage.
Aim: We present our early experience with the left atrial appendage transcatheter closure using the Amplatzer® Cardiac Plug.
Methods: Transcatheter closure was performed in general anaesthesia and under transoesophageal echocardiography control in three patients aged 69, 73 and 61 years (two female). All had atrial fibrillation with high risk of thromboembolic events (CHADS2 score ≥ 2 points). In all of them coumadin treatment was contraindicated.
Results: The procedure time was 112, 109 and 60 min (fluoroscopy time: 25, 29 and 12,5 min). The Amplatzer® Cardiac Plugs of 24, 26 and 22 mm were implanted successfully and without complications. The day after, transthoracic echocardiogram revealed proper position of the implant and complete occlusion of the appendage in all patients. The patients were discharged on antiplatelet treatment.
Conclusion: Transcatheter left atrial appendage closure with the Amplatzer® Cardiac Plug may be a promissing therapeutic option for patients with atrial fibrillation-related high risk of thromboembolic events and with contraindications to anti-vitamin K treatment.
Get Citation

Keywords

atrial fibrillation; brain stroke; transcatheter closure of left atrial appendage

About this article
Title

Transcatheter closure of left atrial appendage with the Amplatzer® Cardiac Plug in patients with atrial fibrillation and high risk of thromboembolic events - early experience

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 68, No 2 (2010)

Pages

250-254

Published online

2010-04-22

Bibliographic record

Kardiol Pol 2010;68(2):250-254.

Keywords

atrial fibrillation
brain stroke
transcatheter closure of left atrial appendage

Authors

Marcin Demkow
Adam Witkowski
Łukasz Cedzyński
Marek Konka
Jai-Wun Park
Anna Wojno
Tomasz Hryniewiecki
Witold Rużyłło

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl